GSN and prostate cancer: Several studies have demonstrated that increased expression of gelsolin is related to lower survival rates among patients with human prostate cancer, lung cancer, and oral cavity cancer.9, 10, 11, 15, 22 Moreover, a negative expression of gelsolin in patients with colon carcinoma closely associated with longer survival rates.13